首页> 外文期刊>Modern Pathology >Utility of FISH in the diagnosis of angiomatoid fibrous histiocytoma: a series of 18 cases
【24h】

Utility of FISH in the diagnosis of angiomatoid fibrous histiocytoma: a series of 18 cases

机译:FISH在诊断血管瘤样纤维组织细胞瘤中的应用:一系列18例

获取原文
       

摘要

Angiomatoid fibrous histiocytoma is a mesenchymal neoplasm of intermediate malignancy and uncertain histogenesis/line of differentiation, which occurs most commonly in the extremities of children to young adults. It has a characteristic appearance characterized by a proliferation of histiocytoid cells with a lymphoid cuff and fibrous pseudocapsule, simulating the appearance of a neoplasm occurring within a lymph node. However, these classic histological features are not always present. Given the variable appearance of the neoplastic cells and the lack of consistently positive immunohistochemical markers, diagnosis can be problematic. Angiomatoid fibrous histiocytoma has been found to harbor three related translocations, a t(12;16)(q13;p11) resulting in a FUS/ATF1 fusion gene, t(12;22)(q13;q12) resulting in a EWSR1/ATF1 fusion, and t(2;22)(q33;q12) resulting in a EWSR1/CREB1 fusion. Fluorescence in situ hybridization (FISH) probes to EWSR1 and FUS, in theory, should detect all three translocations/gene fusions. We evaluated 18 cases of angiomatoid fibrous histiocytoma for rearrangements of EWSR1 and FUS by FISH, the largest series to date. We found that 13 of 17 (76%) cases of angiomatoid fibrous histiocytoma harbored rearrangements of EWSR1; rearrangements of FUS were not detected in any of the cases. This study affirms that the rearrangement of EWSR1 is a common genetic event in angiomatoid fibrous histiocytoma, and is thus useful diagnostically. This study supports the fact that the rearrangement of FUS is present in only a small minority of angiomatoid fibrous histiocytomas. Interestingly, 24% of the cases were translocation negative, and did not contain rearrangements of EWSR1 or FUS by FISH. Although it is possible that these cases contained cryptic rearrangements of EWSR1 or FUS that were not detectable by our FISH probes, it also raises the possibility that another translocation/gene fusion may be present in angiomatoid fibrous histiocytoma. Finally, we discuss some of the potential pitfalls of this technique, including confusion with other mesenchymal neoplasms containing rearrangement of EWSR1, in particular Ewing's sarcoma/PNET.
机译:血管瘤样纤维组织细胞瘤是中度恶性和不确定的组织发生/分化路线的间充质肿瘤,最常见于儿童至年轻人的四肢。它具有特征性的外观,其特征在于具有淋巴囊和纤维状假囊的组织细胞样细胞的增殖,模拟了在淋巴结内发生的肿瘤的出现。但是,这些经典的组织学特征并不总是存在。鉴于肿瘤细胞的外观各不相同,并且缺乏一致的阳性免疫组织化学标记,诊断可能会出现问题。已发现血管瘤样纤维组织细胞瘤具有三个相关的易位,即(12; 16)(q13; p11)导致FUS / ATF1融合基因,t(12; 22)(q13; q12)导致EWSR1 / ATF1融合,以及t(2; 22)(q33; q12)导致EWSR1 / CREB1融合。理论上,针对EWSR1和FUS的荧光原位杂交(FISH)探针应可检测到所有三种易位/基因融合。我们通过FISH评估了18例血管瘤样纤维组织细胞瘤的EWSR1和FUS重排,这是迄今为止最大的系列。我们发现,在17例(76%)血管瘤样纤维组织细胞瘤病例中,EWSR1发生了重排。在任何情况下均未检测到FUS重排。这项研究肯定了EWSR1的重排是血管瘤样纤维组织细胞瘤中常见的遗传事件,因此在诊断上很有用。该研究支持以下事实:FUS的重排仅存在于少数的血管瘤样纤维组织细胞瘤中。有趣的是,有24%的病例为易位阴性,并且不包含FISH引起的EWSR1或FUS重排。尽管这些病例可能包含我们的FISH探针无法检测到的EWSR1或FUS的隐秘重排,但也增加了另一种易位/基因融合可能存在于血管瘤样纤维组织细胞瘤中的可能性。最后,我们讨论了该技术的一些潜在陷阱,包括与其他包含EWSR1重排的间充质肿瘤的混淆,特别是尤因氏肉瘤/ PNET。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号